Letters, Testimony & Filings FDA Approval of the Delandistrogene Moxeparvovec-rokl (ELEVIDYS) Gene Therapy for Duchenne’s Muscular Dystrophy Calls into Question the Agency’s Role as a Careful Gatekeeper November 1, 2023
Letters, Testimony & Filings Testimony before the Food and Drug Administration’s Cellular, Tissue, and Gene Therapy Advisory Committee regarding Exagamglogene Autotemcel Gene Therapy for Sickle Cell Disease (BLA# 125787/0, Vertex Pharmaceuticals) October 31, 2023
Outrage of the Month: Public Comments to Medicare Marred by Financial Conflicts of Interest October 1, 2023
Testimony before the Food and Drug Administration’s Cellular, Tissue, and Gene Therapy Advisory Committee Regarding Debamestrocel (MSC-NTF, NurOwn; Brainstorm Cell Therapeutics) as a Potential Treatment for Amyotrophic Lateral Sclerosis (BLA 125782) September 27, 2023
Press Releases Public Citizen’s President and President Emeritus Release New Book: The Corporate Sabotage of America’s Future and What We Can Do About It September 21, 2023
Testimony before the Food and Drug Administration’s Endocrinologic and Metabolic Drugs Advisory Committee Meeting Regarding the ITCA 650 Drug-Device for Type 2 Diabetes September 21, 2023